Real-time enrollment status for this necrotizing myopathy clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT07103746 |
| Recruiting Status | Recruiting |
| Condition | Necrotizing Myopathy |
| Phase | Clinical Trial |
| Target Enrollment | 30 participants |
| Active Locations | 8 sites in the US |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) |
| Last Updated on CT.gov | June 16, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT07103746 is currently recruiting participants. This clinical trial study for necrotizing myopathy is actively seeking new participants at 8 locations across the United States. The study is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07103746 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07103746 was last updated 3 weeks ago (June 16, 2026). HelloStudys verifies this status automatically.